Dexmedetomidine Infusion in Either Total Intravenous Anesthesia or Inhalational Anesthesia to Improve Surgical Field Visibility in Endoscopic Sinus Surgery
Active, not recruiting
- Conditions
- Rhinosinusitis
- Interventions
- Procedure: functional endoscopic sinus surgery
- Registration Number
- NCT06866145
- Lead Sponsor
- Menoufia University
- Brief Summary
Dexmedetomidine Infusion in either Total Intravenous Anesthesia or Inhalational Anesthesia to Improve Surgical Field Visibility in Endoscopic Sinus Surgery
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- American Society of Anesthesiologists (ASA) class I and II patients undergoing endoscopic sinus surgery in the age group from 18-50 years.
Exclusion Criteria
- History of allergy to medications used in the study, refusal of patients to participate, hepatic or renal dysfunction, chronic pain condition, psychological and neurological disorders
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description TIVA group functional endoscopic sinus surgery patients receives total intravenous anesthesia TIVA group Dexmedetomidine patients receives total intravenous anesthesia inhalational group functional endoscopic sinus surgery patients receives inhalational anesthesia inhalational group Dexmedetomidine patients receives inhalational anesthesia
- Primary Outcome Measures
Name Time Method Surgical field visibility intraoperative Surgical field visibility assessed every 15 minutes based on Boezaart scale
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Dexmedetomidine alpha-2A adrenergic receptor activation mechanisms endoscopic sinus surgery field visibility
Comparative effectiveness dexmedetomidine TIVA vs inhalational anesthesia chronic rhinosinusitis surgical outcomes
Biomarkers predicting dexmedetomidine response in endoscopic sinus surgery patient selection inflammatory markers
Adverse events management strategies dexmedetomidine infusion endoscopic sinus surgery anesthesiology guidelines
Alpha-2 adrenergic agonists combinations dexmedetomidine chronic rhinosinusitis with nasal polyps anesthetic approaches
Trial Locations
- Locations (1)
Menoufia university hospital
🇪🇬Shibin Elkom, Egypt